Poor start to vaccine rollout poses risks to recovery

A decline in GDP in Q1 now seems highly likely, but the bigger concern is that slow vaccination programmes and concerns about virus variants may delay the lifting of restrictions in Q2 and beyond. Meanwhile, we expect confirmation next week that GDP contracted in Q4, and we should learn more about January’s “inflation shock”.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.
By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.

Already a client or trialist? Log in to read this.